Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yongin
Clinical trial register · South Korea

Clinical Trials in Yongin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 143 Yongin-si 20 Yongin 10 Daegu 5 Jeonju 3
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul143 Yongin-si20 Yongin10 Daegu5 Jeonju3
All 23 locations
Target enrolment
to

Trials with a site in Yongin

10 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Yonsei University
Observational
600
Yongin, Daegu, Jeonju
2026-11-09
Not yet open
In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
NCT07622485Cardiovascular Diseases, Acute Coronary Syndrome, Heart Failure, Cardiac Arrhythmia
Yonsei University
Not applicable
1,500
Yongin
2026-07-01
Recruiting
Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart Disease
NCT07367893Ischemic Heart Diease, Non-ischemic Heart Disease
Yonsei University
Observational
10,000
Yongin
2026-04-01
Recruiting
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
NCT06811519Heart Failure, Left Ventricular (LV) Systolic Dysfunction, Body Composition Measurement, Artificial Intelligence (AI)
Yonsei University
Observational
2,000
Yongin
2025-02-24
Recruiting
Yonsei University
Not applicable
226
Yongin
2023-07-31
Active, closed
Yonsei University
Phase 4
200
Yongin
2023-05-03
Active, closed
Yonsei University
Observational
3,600
Yongin
2023-01-05
Active, closed
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
NCT05340361Coronary Artery Disease, Optical Coherence Tomography, Stent
Yonsei University
Observational
30
Yongin
2022-03-23
Active, closed
CREATE Trial, Prospective, Observational Study
NCT05658250Coronary Artery Disease, Drug Eluting Stent
Yonsei University
Observational
300
Yongin
2021-08-03
Active, closed
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191Acute Myocardial Infarction (AMI), Type 2 Diabetes Mellitus (T2DM)
Yonsei University
Observational
200,000
Yongin
2014-09-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/yongin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Yongin that also match the filters currently applied.

How many clinical trials are recruiting in Yongin?

3 of the 10 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yongin), 10 studies
PhaseStudiesRecruitingShare
Observational7270%
Not applicable2120%
Phase 41010%

Most active sponsors

Lead sponsors with the most studies (Yongin)
Lead sponsorStudiesRecruiting
Yonsei University103
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.